Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_assertion description "[The number of different subpopulations of circulating endothelial cells (CECs), plasma levels of vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor 1 and 2 (sVEGFR-1,2) and placenta growth factor (PlGF) were determined in 30 patients with ET and 16 patients with PV.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_assertion evidence source_evidence_literature NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_assertion SIO_000772 20473593 NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_assertion wasDerivedFrom befree-20140225 NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_assertion wasGeneratedBy ECO_0000203 NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP850363.RAxarqXIgwyFZSxVx99C5xdoGbXDJB6hqfha_PF7ZLm-I130_provenance.